Oxylipid Profile of Low-Dose Aspirin Exposure: A Pharmacometabolomics Study
about
Metabolomics: Bridging the Gap between Pharmaceutical Development and Population HealthMetabolomics enables precision medicine: "A White Paper, Community Perspective"Deconstructing the traditional Japanese medicine "Kampo": compounds, metabolites and pharmacological profile of maoto, a remedy for flu-like symptoms.Macrophage-Mediated Clofazimine Sequestration Is Accompanied by a Shift in Host Energy Metabolism.
P2860
Oxylipid Profile of Low-Dose Aspirin Exposure: A Pharmacometabolomics Study
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Oxylipid Profile of Low-Dose Aspirin Exposure: A Pharmacometabolomics Study
@en
type
label
Oxylipid Profile of Low-Dose Aspirin Exposure: A Pharmacometabolomics Study
@en
prefLabel
Oxylipid Profile of Low-Dose Aspirin Exposure: A Pharmacometabolomics Study
@en
P2093
P2860
P50
P356
P1476
Oxylipid Profile of Low-Dose Aspirin Exposure: A Pharmacometabolomics Study
@en
P2093
Adrie Dane
Amber L Beitelshees
Anastasia Georgiades
Faisa Guled
Joshua P Lewis
Katrin Strassburg
Laura M Yerges-Armstrong
Margriet M W B Hendriks
Pharmacometabolomics Research Network
Richard B Horenstein
P2860
P304
P356
10.1161/JAHA.115.002203
P577
2015-10-26T00:00:00Z